Talimogene Laherparepvec
Amgen
['melanoma']
neoadjuvant t-vec efficacy consistent at 5 years for resectable melanoma #esmo22
SVP, Content @MJHLifeSciences. Focused on creating innovative, expert-driven content @OncLive @MedEconomics @AJMC_Journal @Pharmacy_Times @MDMagazine plus more